Source: International Congress 2014 – COPD physiopathology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vukic Dugac, M. Jakopovic, S. Popovic-Grle, B. Barisic, S. Badovinac, M. Samarzija, A. Ruzic (Zagreb, Rijeka, Croatia). Endothelial dysfunction and systemic inflammation in different COPD phenotypes. Eur Respir J 2014; 44: Suppl. 58, 2951

Member's Comments

No comment yet.

Related content which might interest you: Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 COPD: Left ventricular dysfunction, systemic inflammation and endothelial dysfunction Source: International Congress 2014 – Markers Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators Source: International Congress 2014 – Clinical presentations Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014